A cost-utility analysis of multimodal pain rehabilitation in primary healthcare
Authors:
Open Access
- 7 September 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Scandinavian Journal of Pain
- Vol. 21 (1) , 48-58
Abstract
Objectives: Multimodal rehabilitation programs (MMRPs) have been shown to be both cost-effective and an effective method for managing chronic pain in specialist care. However, while the vast majority of patients are treated in primary healthcare, MMRPs are rarely practiced in these settings. Limited time and resources for everyday activities alongside the complexity of chronic pain makes the management of chronic pain challenging in primary healthcare and the focus is on unimodal treatment. In order to increase the use of MMRPs incentives such as cost savings and improved health status in the patient group are needed. The aim of this study was to evaluate the cost-effectiveness of MMRPs for patients with chronic pain in primary healthcare in two Swedish regions. The aim of this study was to evaluate the cost-effectiveness of MMRPs at one-year follow-up in comparison with care as usual for patients with chronic pain in primary healthcare in two Swedish regions. Methods: A cost-utility analysis was performed alongside a prospective cohort study comparing the MMRP with the alternative of continuing with care as usual. The health-related quality of life (HRQoL), using EQ5D, and working situation of 234 participants were assessed at baseline and one-year follow-up. The primary outcome was cost per quality-adjusted life year (QALY) gained while the secondary outcome was sickness absence. An extrapolation of costs was performed based on previous long-term studies in order to evaluate the effects of the MMRP over a five-year time period. Results: The mean (SD) EQ5D index, which measures HRQoL, increased significantly (p<0.001) from 0.34 (0.32) to 0.44 (0.32) at one-year follow-up. Sickness absence decreased by 15%. The cost-utility analysis showed a cost per QALY gained of 18 704 € at one-year follow-up. Conclusions: The results indicate that the MMRP significantly improves the HRQoL of the participants and is a cost-effective treatment for patients with chronic pain in primary healthcare when a newly suggested cost-effectiveness threshold of 19 734 € is implemented. The extrapolation indicates that considerable cost savings in terms of reduced loss of production and gained QALYs may be generated if the effects of the MMRP are maintained beyond one-year follow-up. The study demonstrates potential benefits of MMRPs in primary healthcare for both the patient with chronic pain and the society as a whole. The cost-effectiveness of MMRPs in primary healthcare has scarcely been studied and further long-term studies are needed in these settings.Keywords
Funding Information
- Swedish Research Council (2018-02470.2)
- The Country councils of Östergötland and Västerbotten
- The Swedish Association for Survivors of Polio, Accident and Injury (2019/4)
This publication has 50 references indexed in Scilit:
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statementCost Effectiveness and Resource Allocation, 2013
- Management of chronic pain in primary careCurrent Opinion in Supportive & Palliative Care, 2011
- Cost-effectiveness of guideline-endorsed treatments for low back pain: a systematic reviewEuropean Spine Journal, 2011
- Cost effectiveness of two rehabilitation programmes for neck and back pain patients: A seven year follow-upPain, 2009
- Determinants of work ability and its predictive value for disabilityOccupational Medicine, 2009
- Evaluation of a multiprofessional rehabilitation programme for persistent musculoskeletal-related pain: Economic benefits of return to workJournal of Rehabilitation Medicine, 2008
- Quality of life and maintenance of improvements after early multimodal rehabilitation: A 5-year follow-upDisability and Rehabilitation, 2006
- Functional Rating IndexSpine, 2001
- Analysis of serial measurements in medical research.BMJ, 1990
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983